50 patients scheduled for distal metatarsal osteotomy for hallux valgus were randomized to either continuous wound infiltration with ropivacaine or placebo infusion with saline. Patients were assessed for the primary outcome of pain scores over the first 24 hours after surgery. Secondary outcomes included pain assessment to 6 weeks after surgery, as well as rescue analgesic use, function on the American Orthopaedic Foot and Ankle Society forefoot score, range of motion of the first metatarsophalangeal joint (1st MTPJ), and patient satisfaction. Results demonstrated no statistically significant differences between groups for any of the assessed outcome measures.